National Cancer Institute

FY 2008 Research Funding by Research Topic

Cancer Type Funded Amount
Agent Orange/Dioxin Related $2,066,023
Aging $162,224,132
Alcoholism Research $905,775
Arctic $965,121
Arthritis $1,728,745
Ataxia Telangiectasia $3,788,979
Autoimmune Diseases $13,793,985
Basic Behavioral and Social Science $76,738,503
Behavioral and Social Science $292,073,805
Biochemical Epidemiology $230,381,157
Bone Marrow Transplantation $55,539,605
Cancer $4,827,552,152
Cancer Survivorship $198,795,071
Cervical Cancer Education $6,082,037
Chemoprevention $168,074,275
Chemotherapy $513,056,980
Childhood Cancers $189,672,374
Chronic Myeloproliferative Disorders $31,297,852
Contraception and Reproduction Research $4,265,509
Depression Research $6,326,003
Diabetes $8,526,424
Diagnostic Radiology $187,317,907
Digestive Diseases $439,873,191
Down Syndrome $955,504
Gene Therapy $76,968,945
Gene Therapy Clinical Trials $10,763,892
Genetic Testing $157,377,283
Helicobacter Pylori $7,199,113
Hematology $482,375,634
Herpes - Genital $625,244
Herpes - Other $58,304,436
Herpes - Total $58,389,449
HHV8 $25,642,169
Hospice $9,688,242
HTLV - II $1,091,195
Inflammatory Bowel Disease $3,388,817
Interferon $35,442,662
Lupus $383,823
Metastasis $366,310,151
Monoclonal Antibodies $43,388,843
Neurofibromatosis $5,923,923
Neurosciences Research $159,910,680
Nuclear Magnetic Resonance Imaging (NMR) $84,992,252
Nursing Oncology $19,933,472
Organ Transplantation Research $65,435,562
Pesticides $4,282,082
Sleep Disorders $7,576,161
Smoking Behavior $61,605,808
Surgery $72,662,767
Taxol $63,184,616
Telehealth $98,871,696
Telemedicine $15,593,076
Tuberous Sclerosis $4,861,046
Tumor Necrosis Factor $26,007,370